 | • レポートコード：B-GIR08C1205 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール • 産業分類：Medical Care |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、小児期欠神癲癇治療の世界市場について調べ、まとめました。種類別セグメントは、エトサクシミド、バルプロエート、ラモトリジン、CX-8998、カンナビジオール経口液剤等、用途別セグメントは、等に区分しました。小児期欠神癲癇治療の世界市場概観、企業動向、企業別小児期欠神癲癇治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・小児期欠神癲癇治療の市場概観 ・小児期欠神癲癇治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・小児期欠神癲癇治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・小児期欠神癲癇治療の世界市場規模 ・小児期欠神癲癇治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・小児期欠神癲癇治療のアメリカ市場規模推移 ・小児期欠神癲癇治療のカナダ市場規模推移 ・小児期欠神癲癇治療のメキシコ市場規模推移 ・小児期欠神癲癇治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・小児期欠神癲癇治療のドイツ市場規模推移 ・小児期欠神癲癇治療のイギリス市場規模推移 ・小児期欠神癲癇治療のロシア市場規模推移 ・小児期欠神癲癇治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・小児期欠神癲癇治療の日本市場規模推移 ・小児期欠神癲癇治療の中国市場規模推移 ・小児期欠神癲癇治療の韓国市場規模推移 ・小児期欠神癲癇治療のインド市場規模推移 ・小児期欠神癲癇治療の東南アジア市場規模推移 ・小児期欠神癲癇治療の南米市場分析（ブラジル、アルゼンチン等） ・小児期欠神癲癇治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・小児期欠神癲癇治療の種類別分析/販売量、売上、市場シェア（エトサクシミド、バルプロエート、ラモトリジン、CX-8998、カンナビジオール経口液剤） ・小児期欠神癲癇治療の用途別分析/市場規模（） ・小児期欠神癲癇治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・小児期欠神癲癇治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Childhood absence epilepsy (CAE), also known as pyknolepsy, is an idiopathic generalized epilepsy which occurs in otherwise normal children. The age of onset is between 4–10 years with peak age between 5–7 years. Children have absence seizures which although brief (~4–20 seconds), they occur frequently, sometimes in the hundreds per day. The absence seizures of CAE involve abrupt and severe impairment of consciousness. Mild automatisms are frequent, but major motor involvement early in the course excludes this diagnosis. The EEG demonstrates characteristic “typical 3Hz spike-wave” discharges. Prognosis is excellent in well-defined cases of CAE with most patients “growing out” of their epilepsy.
Scope of the Report:
The global Childhood Absence Epilepsy Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Childhood Absence Epilepsy Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Childhood Absence Epilepsy Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Childhood Absence Epilepsy Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Pfizer
GlaxoSmithKline
Cavion Inc
AbbVie
Teva Pharmaceutical
Insys Therapeutics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Ethosuximide
Valproate
Lamotrigine
CX-8998
Cannabidiol Oral Solution
Market Segment by Applications, can be divided into
Typical Absence Seizures
Atypical Absence Seizures
Table of Contents
1 Childhood Absence Epilepsy Treatment Market Overview
1.1 Product Overview and Scope of Childhood Absence Epilepsy Treatment
1.2 Classification of Childhood Absence Epilepsy Treatment by Types
1.2.1 Global Childhood Absence Epilepsy Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Childhood Absence Epilepsy Treatment Revenue Market Share by Types in 2018
1.2.3 Ethosuximide
1.2.4 Valproate
1.2.5 Lamotrigine
1.2.6 CX-8998
1.2.7 Cannabidiol Oral Solution
1.3 Global Childhood Absence Epilepsy Treatment Market by Application
1.3.1 Global Childhood Absence Epilepsy Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Typical Absence Seizures
1.3.3 Atypical Absence Seizures
1.4 Global Childhood Absence Epilepsy Treatment Market by Regions
1.4.1 Global Childhood Absence Epilepsy Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Childhood Absence Epilepsy Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Childhood Absence Epilepsy Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Childhood Absence Epilepsy Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Childhood Absence Epilepsy Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Childhood Absence Epilepsy Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Childhood Absence Epilepsy Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Childhood Absence Epilepsy Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.2 Childhood Absence Epilepsy Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Cavion Inc
2.3.1 Business Overview
2.3.2 Childhood Absence Epilepsy Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Cavion Inc Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 AbbVie
2.4.1 Business Overview
2.4.2 Childhood Absence Epilepsy Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AbbVie Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Teva Pharmaceutical
2.5.1 Business Overview
2.5.2 Childhood Absence Epilepsy Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teva Pharmaceutical Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Insys Therapeutics
2.6.1 Business Overview
2.6.2 Childhood Absence Epilepsy Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Insys Therapeutics Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Childhood Absence Epilepsy Treatment Market Competition, by Players
3.1 Global Childhood Absence Epilepsy Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Childhood Absence Epilepsy Treatment Players Market Share
3.2.2 Top 10 Childhood Absence Epilepsy Treatment Players Market Share
3.3 Market Competition Trend
4 Global Childhood Absence Epilepsy Treatment Market Size by Regions
4.1 Global Childhood Absence Epilepsy Treatment Revenue and Market Share by Regions
4.2 North America Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
5 North America Childhood Absence Epilepsy Treatment Revenue by Countries
5.1 North America Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)
5.2 USA Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
6 Europe Childhood Absence Epilepsy Treatment Revenue by Countries
6.1 Europe Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)
6.2 Germany Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
6.4 France Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Childhood Absence Epilepsy Treatment Revenue by Countries
7.1 Asia-Pacific Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)
7.2 China Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
7.5 India Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
8 South America Childhood Absence Epilepsy Treatment Revenue by Countries
8.1 South America Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)
8.2 Brazil Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Childhood Absence Epilepsy Treatment by Countries
9.1 Middle East and Africa Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
10 Global Childhood Absence Epilepsy Treatment Market Segment by Type
10.1 Global Childhood Absence Epilepsy Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Childhood Absence Epilepsy Treatment Market Forecast by Type (2019-2024)
10.3 Ethosuximide Revenue Growth Rate (2014-2024)
10.4 Valproate Revenue Growth Rate (2014-2024)
10.5 Lamotrigine Revenue Growth Rate (2014-2024)
10.6 CX-8998 Revenue Growth Rate (2014-2024)
10.7 Cannabidiol Oral Solution Revenue Growth Rate (2014-2024)
11 Global Childhood Absence Epilepsy Treatment Market Segment by Application
11.1 Global Childhood Absence Epilepsy Treatment Revenue Market Share by Application (2014-2019)
11.2 Childhood Absence Epilepsy Treatment Market Forecast by Application (2019-2024)
11.3 Typical Absence Seizures Revenue Growth (2014-2019)
11.4 Atypical Absence Seizures Revenue Growth (2014-2019)
12 Global Childhood Absence Epilepsy Treatment Market Size Forecast (2019-2024)
12.1 Global Childhood Absence Epilepsy Treatment Market Size Forecast (2019-2024)
12.2 Global Childhood Absence Epilepsy Treatment Market Forecast by Regions (2019-2024)
12.3 North America Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)
12.6 South America Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Childhood Absence Epilepsy Treatment Picture
Table Product Specifications of Childhood Absence Epilepsy Treatment
Table Global Childhood Absence Epilepsy Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Childhood Absence Epilepsy Treatment Revenue Market Share by Types in 2018
Figure Ethosuximide Picture
Figure Valproate Picture
Figure Lamotrigine Picture
Figure CX-8998 Picture
Figure Cannabidiol Oral Solution Picture
Table Global Childhood Absence Epilepsy Treatment Revenue (Million USD) by Application (2014-2024)
Figure Childhood Absence Epilepsy Treatment Revenue Market Share by Applications in 2018
Figure Typical Absence Seizures Picture
Figure Atypical Absence Seizures Picture
Table Global Market Childhood Absence Epilepsy Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Childhood Absence Epilepsy Treatment Type and Applications
Table Pfizer Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Childhood Absence Epilepsy Treatment Type and Applications
Table GlaxoSmithKline Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Cavion Inc Basic Information, Manufacturing Base and Competitors
Table Cavion Inc Childhood Absence Epilepsy Treatment Type and Applications
Table Cavion Inc Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Childhood Absence Epilepsy Treatment Type and Applications
Table AbbVie Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Childhood Absence Epilepsy Treatment Type and Applications
Table Teva Pharmaceutical Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Insys Therapeutics Basic Information, Manufacturing Base and Competitors
Table Insys Therapeutics Childhood Absence Epilepsy Treatment Type and Applications
Table Insys Therapeutics Childhood Absence Epilepsy Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Childhood Absence Epilepsy Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Childhood Absence Epilepsy Treatment Revenue Share by Players (2014-2019)
Figure Global Childhood Absence Epilepsy Treatment Revenue Share by Players in 2017
Figure Global Childhood Absence Epilepsy Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Childhood Absence Epilepsy Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Childhood Absence Epilepsy Treatment Revenue Market Share in 2018
Figure Global Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Childhood Absence Epilepsy Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Childhood Absence Epilepsy Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Childhood Absence Epilepsy Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Childhood Absence Epilepsy Treatment Revenue Market Share by Regions in 2018
Figure North America Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure South America Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Table North America Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)
Table North America Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Childhood Absence Epilepsy Treatment Revenue Market Share by Countries in 2018
Figure USA Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Table Europe Childhood Absence Epilepsy Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Childhood Absence Epilepsy Treatment Revenue Market Share by Countries in 2018
Figure Germany Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure UK Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure France Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Childhood Absence Epilepsy Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Childhood Absence Epilepsy Treatment Revenue Market Share by Countries in 2018
Figure China Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure India Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Table South America Childhood Absence Epilepsy Treatment Revenue by Countries (2014-2019)
Table South America Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Childhood Absence Epilepsy Treatment Revenue Market Share by Countries in 2018
Figure Brazil Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Childhood Absence Epilepsy Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Childhood Absence Epilepsy Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Childhood Absence Epilepsy Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Childhood Absence Epilepsy Treatment Revenue and Growth Rate (2014-2019)
Table Global Childhood Absence Epilepsy Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Childhood Absence Epilepsy Treatment Revenue Share by Type (2014-2019)
Figure Global Childhood Absence Epilepsy Treatment Revenue Share by Type (2014-2019)
Figure Global Childhood Absence Epilepsy Treatment Revenue Share by Type in 2018
Table Global Childhood Absence Epilepsy Treatment Revenue Forecast by Type (2019-2024)
Figure Global Childhood Absence Epilepsy Treatment Market Share Forecast by Type (2019-2024)
Figure Global Ethosuximide Revenue Growth Rate (2014-2019)
Figure Global Valproate Revenue Growth Rate (2014-2019)
Figure Global Lamotrigine Revenue Growth Rate (2014-2019)
Figure Global CX-8998 Revenue Growth Rate (2014-2019)
Figure Global Cannabidiol Oral Solution Revenue Growth Rate (2014-2019)
Table Global Childhood Absence Epilepsy Treatment Revenue by Application (2014-2019)
Table Global Childhood Absence Epilepsy Treatment Revenue Share by Application (2014-2019)
Figure Global Childhood Absence Epilepsy Treatment Revenue Share by Application (2014-2019)
Figure Global Childhood Absence Epilepsy Treatment Revenue Share by Application in 2018
Table Global Childhood Absence Epilepsy Treatment Revenue Forecast by Application (2019-2024)
Figure Global Childhood Absence Epilepsy Treatment Market Share Forecast by Application (2019-2024)
Figure Global Typical Absence Seizures Revenue Growth Rate (2014-2019)
Figure Global Atypical Absence Seizures Revenue Growth Rate (2014-2019)
Figure Global Childhood Absence Epilepsy Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Childhood Absence Epilepsy Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Childhood Absence Epilepsy Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)
Figure Europe Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)
Figure South America Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Childhood Absence Epilepsy Treatment Revenue Market Forecast (2019-2024)
世界のてんかんの診断と治療市場：市場規模・現状・予測 Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the …- 世界の小児てんかん治療市場：市場規模・現状・予測 Epilepsy is one of the most common and challenging neurologic disorders affecting children.Pediatric epilepsies present particular challenges, including correct diagnoses, comorbidities and interactions with developmental processes in the brain. In 2018, the global Pediatric Epilepsy Therapeutics ma…
- 小児癲癇治療市場：世界及び中国市場分析・予測（～2024年） Pediatric Epilepsy Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Pediatric Epilepsy Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Pediat…
- すくみ足治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Freezing of Gait Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China…
- 世界の口腔がんの治療市場：市場規模・現状・予測 Oral cancer, also known as mouth cancer, is a type of head and neck cancer and is any cancerous tissue growth located in the oral cavity. It may arise as a primary lesion originating in any of the tissues in the mouth, by metastasis from a distant site of origin, or by extension from a neighboring a…